Craft

Valbiotis

Stock Price

€1.3

2024-10-29

Market Capitalization

€21 M

2024-10-29

Revenue

€905 K

FY, 2025

Valbiotis Summary

Company Summary

Overview
Valbiotis is a company that develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. The Company's “Nutrition Healthcare” approach seeks to develop tools designed to prevent type 2 diabetes, NASH (non-alcoholic steatohepatitis) and obesity. Valbiotis' mission is to help millions of people all over the world to live for a longer time, in good health.
Type
Public
Status
Active
Founded
2014
HQ
Perigny, FR | view all locations
Website
http://valbiotis.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Laurent Levy

    Laurent Levy, Chairman of the Supervisory Board

  • Sébastien Peltier

    Sébastien Peltier, CEO & Co-Founder

  • Pascal Sirvent
  • Agnès Tixier

    Agnès Tixier, Supervisory Board Member

LocationsView all

1 location detected

  • Perigny HQ

    France

    Zone Industrielle des 4 Chevaliers, Bâtiment 12F, Rue Paul Vatine

Valbiotis Financials

Summary Financials

Revenue (FY, 2025)
€905.0K
Gross profit (FY, 2025)
€219.0K
Net income (FY, 2025)
(€9.4M)
Cash (FY, 2025)
€8.7M
EBIT (FY, 2025)
(€9.5M)
Enterprise value
$17.4M

Footer menu